MedPath

Effect of Interferential l Therapy on Low Back Pain

Not Applicable
Completed
Conditions
Low Back Pain
Interventions
Other: Interferential therapy
Registration Number
NCT03961477
Lead Sponsor
Ahlia University
Brief Summary

Background: Chronic non-specific low back pain is defined as unknown mechanical musculoskeletal pain lasting more than 3 months. Electrotherapy is a non-pharmacologic, non-invasive and simple method back pain treatment that is mainly applied using interferential (IF) therapy. The current study was designed to investigate the effect of IF on pain, range of motion, and quality of life in patients with chronic non-specific low back pain. Materials and methods: 61 patients suffered from chronic non-specific low back pain (CNLBP) were randomly assigned to IF group (n=30) and placebo IF (n=31). The entire patient received suggested exercise 3 times per week for 4 weeks. The outcome measures were visual analogue scale (VAS), lumbar range of motion (ROM) in terms of flexion\& extension and the Short Form-36 (SF-36) health questionnaire to evaluate the quality of life (QOL).

Detailed Description

Participants The study was conducted in outpatient clinics in Cairo University Hospitals. 60 patients (29 males and 31 females) were invited to participate in the current study. Subjects were included in the study if they had LBP of at least three months duration and aged between 25 and 60 years. Patients with spinal pathology (tumor, nerve root, fracture, and compromise), cardiopulmonary conditions, pregnancy, and received physiotherapy in the last eight weeks or any contraindications to the use of electrotherapy were excluded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria

*Subjects were included in the study if they had LBP of at least three months duration * Age between 25 and 60 years.

Exclusion Criteria
  • Patients with spinal pathology (tumor, nerve root, fracture, and compromise),
  • Cardiopulmonary conditions
  • Pregnancy,
  • Received physiotherapy in the last eight weeks
  • Any contraindications to the use of electrotherapy were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IF groupInterferential therapyInterferential therpapy
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale (VAS)6 months

The severity of pain was evaluated using a visual analogue scale (VAS). The participants were requested to put a line on the scale perpendicularly that matched to their pain intensity. VAS scores represent the pain intensity as none, mild, moderate, or severe. The accompanying cutoff was used for the pain scale: 0- 4 , no pain; 5- 44, mild pain; 45- 74, moderate pain; and 75-100, severe pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Dr Sayed Tanatwy

🇪🇬

Giza, Egypt

Dr Dalia Kamel

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath